Amyotrophic lateral sclerosis (ALS) is a fatal, multigenic, multifactorial, and non-cell
autonomous neurodegenerative disease characterized by upper and lower motor neuron …

Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease, which is characterized by
the degeneration of motor neurons in the motor cortex and the spinal cord and subsequently …

The level of lipopolysaccharide (LPS) is higher in the blood and brains of patients with
Alzheimer's disease (AD), and this phenomenon is strongly linked to AD-related neuronal …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that progressively
affects motoneurons, causing muscle atrophy and evolving to death. Astrocytes inhibit the …

We have reported that pretreatment with the clinically approved superoxide dismutase
mimetic, Tempol (4-hydroxy-2, 2, 6, 6-tetramethylpiperidine-N-oxyl), blunts the …

Fentanyl is a high-potency opioid receptor agonist that elicits profound analgesia and
suppression of breathing in humans and animals. To date, there is limited evidence as to …

Background Bronchopulmonary dysplasia (BPD) is a major complication of premature
infants and an important cause of morbidity and mortality. This study investigates the effect of …

Neuroinflammation is a fundamental feature in the pathogenesis of amyotrophic lateral
sclerosis (ALS) and arises from the activation of astrocytes and microglial cells. Previously …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease commonly treated with
riluzole, a small molecule that may act via modulation of glutamatergic neurotransmission …

Introduction The brainstem is an important component in the pathology of amyotrophic
lateral sclerosis (ALS). Although neuroimaging studies have shown multiple structural …